Search results for "Extracorporeal"

showing 10 items of 124 documents

Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation

2016

Echinocandins are currently considered the first-line treatment for invasive candidiasis (IC) in the intensive care unit (ICU) [1, 2]. However, extracorporeal membrane oxygenation (ECMO), a rescue therapy used in patients with severe acute respiratory distress syndrome (ARDS) [3], could alter the pharmacokinetics of certain drugs [4]. We prescribed anidulafungin for suspected IC in a patient with severe ARDS on ECMO and measured the plasma concentrations of the drug using high-performance liquid chromatography (HPLC).

0301 basic medicineDrugARDSLettermedia_common.quotation_subjectmedicine.medical_treatment030106 microbiologyCritical Care and Intensive Care Medicinelaw.invention03 medical and health sciencesEchinocandins0302 clinical medicinePharmacokineticsRescue therapylawHemofiltrationExtracorporeal membrane oxygenationMedicine030212 general & internal medicinemedia_commonExtracorporeal membrane oxygenationAcute respiratory distress syndromebusiness.industrymedicine.diseaseIntensive care unitAnesthesiaAnidulafunginbusinessmedicine.drugCritical Care
researchProduct

Low-energy extracorporeal shockwave therapy (ESWT) improves metaphyseal fracture healing in an osteoporotic rat model.

2017

Purpose As result of the current demographic changes, osteoporosis and osteoporotic fractures are becoming an increasing social and economic burden. In this experimental study, extracorporeal shock wave therapy (ESWT), was evaluated as a treatment option for the improvement of osteoporotic fracture healing. Methods A well-established fracture model in the metaphyseal tibia in the osteoporotic rat was used. 132 animals were divided into 11 groups, with 12 animals each, consisting of one sham-operated group and 10 ovariectomized (osteoporotic) groups, of which 9 received ESWT treatment. Different energy flux intensities (0.15 mJ/mm2, 0.35 mJ/mm2, or 0.55 mJ/mm2) as well as different numbers o…

0301 basic medicineExtracorporeal Shockwave TherapyCritical Care and Emergency Medicinemedicine.medical_treatmentOsteoporosisTest StatisticsDentistryGene Expressionlcsh:MedicineRats Sprague-Dawley0302 clinical medicineMathematical and Statistical TechniquesAnimal CellsMedicine and Health SciencesReproductive System ProceduresConnective Tissue Diseaseslcsh:ScienceMusculoskeletal SystemTrauma MedicineConnective Tissue CellsFracture Healing030222 orthopedicsMultidisciplinaryBiomechanicsBone FractureConnective TissueExtracorporeal shockwave therapyPhysical SciencesOvariectomized ratFemaleAnatomyCellular TypesTraumatic InjuryStatistics (Mathematics)Research ArticleOvariectomySurgical and Invasive Medical ProceduresBone healingResearch and Analysis Methods03 medical and health sciencesRheumatologymedicineGeneticsAnimalsTibiaStatistical MethodsSkeletonAnalysis of VarianceOsteoblastsSurgical ExcisionTibiabusiness.industrylcsh:RBiology and Life SciencesBone fractureCell Biologymedicine.diseaseRatsDisease Models Animal030104 developmental biologyBiological TissueAdjunctive treatmentOsteoporosislcsh:QbusinessOsteoporotic FracturesMathematicsPLoS ONE
researchProduct

Effectiveness of Shock Wave Therapy as a Treatment for Spasticity: A Systematic Review

2021

Background: The purpose of this study was to collect and analyse the available scientific evidence on the effectiveness of shock wave therapy as a treatment for spasticity. Methods: the search was performed in the following databases: PubMed, PEDro, Cochrane, Embase, and the Virtual Health Library. All publications from November 2009 to November 2019 were selected that included a sample of patients with spasticity and prior suspension of botulinum toxin, to whom shock wave therapy was applied. The methodological quality of the articles was evaluated using the Jadad scale and the pyramid of quality of scientific evidence. Results: 25 studies involving 866 participants with spasticity were se…

030506 rehabilitationmedicine.medical_specialtyshock wavemedicine.medical_treatmentReviewlcsh:RC321-571Scientific evidence03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineSpasticitylcsh:Neurosciences. Biological psychiatry. Neuropsychiatrymuscle spasticityProtocol (science)business.industryGeneral Neurosciencespasticityextracorporeal shockwave therapyBotulinum toxinJadad scaleShock wave therapyExtracorporeal shockwave therapyFunctional independencemedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgerymedicine.drugBrain Sciences
researchProduct

Indications for ECMO: we need to look at the patient first

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryContraindicationsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEHeartExtracorporeal Membrane OxygenationAnesthesiology and Pain MedicinemedicineHumansRespiratory InsufficiencyIntensive care medicinebusinessLungMinerva Anestesiologica
researchProduct

Do ventilatory parameters influence outcome in patients with severe acute respiratory infection? Secondary analysis of an international, multicentre1…

2021

Purpose: To investigate the possible association between ventilatory settings on the first day of invasive mechanical ventilation (IMV) and mortality in patients admitted to the intensive care unit (ICU) with severe acute respiratory infection (SARI). Materials and methods: In this pre-planned sub-study of a prospective, multicentre observational study, 441 patients with SARI who received controlled IMV during the ICU stay were included in the analysis. Results: ICU and hospital mortality rates were 23.1 and 28.1%, respectively. In multivariable analysis, tidal volume and respiratory rate on the first day of IMV were not associated with an increased risk of death; however, higher driving pr…

ARDSSoins intensifs réanimationmedicine.medical_treatmentAirway pressuresPEEP positive end-expiratory pressureCritical Care and Intensive Care Medicinelaw.inventionHypoxemiaCohort StudiesPositive-Pressure RespirationMechanical ventilationSARI severe acute respiratory infectionlawHospital MortalityProspective StudiesIQR interquartile rangesProspective cohort studyRCT randomized controlled trialTidal volumeSOFA Sequential Organ Failure AssessmentSAPS Simplified Acute Physiology ScoreIntensive care unitVCV volume-controlled ventilationHIV human immunodeficiency virusIntensive Care UnitsIC GLOSSARI Intensive Care Global Study on Severe Acute Respiratory Infectionmedicine.symptomCohort studyLOS length of staymedicine.medical_specialtyVt tidal volumeCOPD Chronic obstructive pulmonary diseaseNYHA New York Heart Association.PCV pressure-controlled ventilationArticleInternal medicineICU Intensive Care UnitSIMV Synchronized intermittent mandatory ventilationmedicineTidal VolumeHumansDP driving pressurePEEPARDS acute respiratory distress syndromeMechanical ventilationbusiness.industryOdds ratioPneumoniaPlateau pressuremedicine.diseaseRespiration ArtificialVILI ventilator induced lung injuryCI confidence intervalOR odds ratioIMV invasive mechanical ventilationCPAP continuous positive airway pressureARDSbusinessSD standard deviationECMO extracorporeal membrane oxygenationPBW predicted body weightPplat plateau pressure
researchProduct

On the question of extracorporeal hemodialysis in diquat intoxication.

1975

Extracorporeal hemodialyses were carried out in a female patient with severe diquat intoxication. Diquat clearance was on average, 3.17 ml/min. Only 0.84 mg diquat could be eliminated from the blood serum by 11.5 hrs of dialysis. Hemodialysis is therefore not an efficient technique for removing amounts of diquat from the organism that are toxicologically relevant one day after ingestion.

AdultChromatographyTime FactorsHealth Toxicology and Mutagenesismedicine.medical_treatmentPyridinium CompoundsGeneral MedicineToxicologyDiquatExtracorporealExtracorporeal hemodialysischemistry.chemical_compoundBlood serumchemistryParaquatRenal DialysisAnesthesiamedicineIngestionDiquatHumansFemaleHemodialysisDialysisArchives of toxicology
researchProduct

Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy: initial experience

2006

BACKGROUND:  In contrast to other extracorporeal treatments no established regime exists for anticoagulation with low-molecular-weight heparin (LMWH) in plasmapheresis therapy. A study was conducted to investigate whether LMWH (dalteparin-Na) is suitable as an effective anticoagulant in plasmapheresis therapy. STUDY DESIGN AND METHODS:  Eleven patients with autoimmune neurological diseases and the necessity for a plasmapheresis therapy were enrolled. A capillary membrane filter was used. A total of 2000 mL of human plasma was isovolumetrically exchanged per plasmapheresis cycle. The anticoagulation was accomplished with a single bolus of LMWH (dalteparin) of 80 to 90 IU per kg of body weigh…

AdultDalteparinmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentImmunologyLow molecular weight heparinGuillain-Barre SyndromeExtracorporealBolus (medicine)Myasthenia GravismedicineHumansImmunology and AllergyMonitoring PhysiologicDalteparin sodiumbusiness.industryAnticoagulantAnticoagulantsPlasmapheresisHematologyHeparinSurgerySingle bolusAnesthesiaPlasmapheresisbusinessmedicine.drugTransfusion
researchProduct

Efficacy of Focused Extracorporeal Shock Wave Therapy in Chronic Low Back Pain: A Prospective Randomized 3-Month Follow-Up Study.

2022

BACKGROUND Extracorporeal shock wave therapy (ESWT) is a modern physiotherapeutic method that is useful for treating musculoskeletal conditions. There are still limited data from well-designed studies evaluating the clinical efficiency of ESWT in low back pain (LBP). Therefore, this study aimed to assess the effectiveness of the focused ESWT (fESWT) in reducing pain and improving the functional status of patients with chronic LBP. MATERIAL AND METHODS The study involved 40 patients with L5-S1 discopathy with chronic LBP pain who were randomized into 2 groups: group A (n=20, mean age of 42.3±13.1 years) and group B (n=20, mean age of 45.4±14 years). Group A was an experimental group treated …

AdultExtracorporeal Shockwave TherapyLipopolysaccharidesGeneral MedicineMiddle Agedfunctional statusTreatment OutcomeRandomized controlled trialHumansProspective Studieschronic painLow Back PainPhysical Therapy ModalitiesFollow-Up StudiesMedical science monitor : international medical journal of experimental and clinical research
researchProduct

The Effectiveness Of Radial Extracorporeal Shock Wave Therapy In Patients With Chronic Low Back Pain: A Prospective, Randomized, Single-Blinded Pilot…

2019

Karolina Walewicz,1 Jakub Taradaj,2,3 Katarzyna Rajfur,1 Kuba Ptaszkowski,4 Michał Tomasz Kuszewski,2 Mirosław Sopel,5 Robert Dymarek5 1Faculty of Physiotherapy, Opole Medical School, Opole, Poland; 2Institute of Physiotherapy and Health Sciences, Academy of Physical Education, Katowice, Poland; 3College of Rehabilitation Sciences, University of Manitoba, Winnipeg, MB, Canada; 4Department of Physiotherapy, Wroclaw Medical University, Wroclaw, Poland; 5Department of Nervous System Diseases, Wroclaw Medical University, Wroclaw, PolandCorrespondence: Robert DymarekDepartment of Nervous System Diseases, Faculty of Health Sciences, Wroclaw Medical University, Bartla 5, Wroclaw 51-618, PolandTe…

AdultExtracorporeal Shockwave TherapyMaleExtracorporeal shock wave therapyVisual analogue scalePilot Projects03 medical and health sciences0302 clinical medicineHumansPain ManagementMedicinephysical therapySingle-Blind MethodIn patientProspective Studies030212 general & internal medicineOriginal ResearchPain Measurementfunctional statebusiness.industryESWTshock wavesGeneral MedicinePain scaleMiddle AgedLow back painChronic low back painOswestry Disability IndexTreatment OutcomeAnesthesiaClinical Interventions in AgingHomogeneous groupFemaleGeriatrics and Gerontologymedicine.symptombusinessLow Back Pain030217 neurology & neurosurgeryClinical Interventions in Aging
researchProduct

Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their car…

2019

Background Acute respiratory distress syndrome (ARDS) survivors are affected with long-term physical/mental impairments, with improvements limited mostly to the first year after intensive care (ICU) discharge. Furthermore, caregivers of ICU patients exhibit psychological problems after family-member recovery. We evaluated the long-term physical and mental recovery of ARDS survivors treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO), and the long-term psychological impact on their caregivers. Methods Single-center prospective evaluation of a retrospective cohort of 75 ARDS patients treated with VV-ECMO during a seven-year period (25.10.2009-11.08.2016). Primary outcomes w…

AdultMaleARDSPediatricsmedicine.medical_specialtyPopulationAnxietyStress Disorders Post-Traumatic03 medical and health sciences0302 clinical medicineExtracorporeal Membrane OxygenationTracheostomyQuality of life030202 anesthesiologyIntensive careMedicineHumansSurvivorseducationDepression (differential diagnoses)Retrospective StudiesPatient health questionnaireeducation.field_of_studyPsychological TestsRespiratory Distress Syndromebusiness.industryDepression030208 emergency & critical care medicineRetrospective cohort studyRecovery of FunctionLength of StayMiddle Agedmedicine.diseasePatient Health QuestionnaireCritical careAnesthesiology and Pain MedicineTreatment OutcomeCaregiversQuality of LifeAnxietyFemalemedicine.symptombusinessFollow-Up StudiesMinerva anestesiologica
researchProduct